A retroplacental hematoma is a blood clot that forms between the placenta and the uterine wall, and yes, it carries more risk than the more common subchorionic type. It occurs when a spiral artery in the uterine lining ruptures under high pressure, pushing blood into the space where the placenta attaches. This can interfere with the placenta’s blood supply and, in serious cases, cause the placenta to partially or fully separate from the uterus. That said, severity varies widely depending on the size of the hematoma, when it’s detected, and how closely it’s monitored.
How It Differs From a Subchorionic Hematoma
Not all placental blood clots carry the same level of concern. Subchorionic hematomas, the most common type found during pregnancy, involve low-pressure bleeding from veins at the edge of the placenta. They form between the membranes and the uterine wall rather than directly behind the placenta itself. Many resolve on their own without complications.
Retroplacental hematomas are rarer and originate from high-pressure arterial bleeding directly beneath the placenta. Because they sit between the placenta and the tissue anchoring it to the uterus, they can disrupt blood flow to the baby more directly. A study from the Icahn School of Medicine at Mount Sinai found that a retroplacental position was significantly correlated with worse outcomes for both the mother and baby compared to subchorionic hematomas detected at the same gestational age.
How Common It Is
Estimates vary depending on the population studied. In industrialized countries, retroplacental hematomas occur in roughly 0.25% to 1% of pregnancies. In developing countries, where risk factors like hypertension and anemia are more prevalent, rates climb to between 4.5% and 6%. A case-control study at a maternal health center in Niger recorded retroplacental hematomas in about 5.2% of deliveries during the study period.
Risks to the Baby
The primary danger is placental abruption, where the hematoma grows large enough to peel the placenta away from the uterine wall. When abruption occurs, the risk of fetal death reaches about 20%. Even without full abruption, a retroplacental hematoma raises the likelihood of several complications. Compared to pregnancies without hematomas, those with retroplacental clots show roughly 2.4 times the risk of fetal growth restriction, 2.6 times the risk of fetal distress, and 2.3 times the risk of preterm delivery. Babies born from these pregnancies are about 5.6 times more likely to need neonatal intensive care.
Meconium-stained amniotic fluid, a sign the baby may be under stress, is also about twice as common. These risks don’t mean every retroplacental hematoma leads to a poor outcome, but they explain why this type of clot gets closer surveillance than a subchorionic one.
Risks to the Mother
For the mother, the main concerns are placental abruption and its downstream effects. Full abruption carries roughly a 1% maternal mortality rate, primarily from severe hemorrhage or a clotting disorder called disseminated intravascular coagulation, where the body’s clotting system goes into overdrive and then fails. Retroplacental hematomas are also associated with preeclampsia, a condition involving dangerously high blood pressure that can damage organs if untreated.
What Symptoms to Watch For
Some retroplacental hematomas cause no symptoms at all and are discovered only on a routine ultrasound. When symptoms do appear, vaginal bleeding is the most common. Unlike the painless spotting that sometimes accompanies subchorionic hematomas, retroplacental bleeding can present alongside a more alarming combination of signs: sudden abdominal pain, a uterus that feels rigid or tender to the touch, and changes in the baby’s movement. This triad of symptoms, known as the classic signs of placental abruption, calls for immediate medical evaluation.
Painless bleeding without other symptoms is also possible and doesn’t necessarily signal abruption, but it still warrants prompt assessment to rule out progression.
How Size Affects the Outlook
The size of the hematoma relative to the placenta matters more than its absolute dimensions. A large hematoma, generally one that strips 30% to 50% or more of the placenta away from the uterine wall, can compress the gestational sac and significantly worsen the prognosis. Hematomas exceeding 50 mL in volume are also considered high risk. Smaller clots that involve less than 20% of the placental surface tend to have better outcomes, though location behind the placenta still raises the concern level compared to a subchorionic clot of the same size.
How It’s Monitored
When a retroplacental hematoma is found on ultrasound but there are no signs of active abruption (no vaginal bleeding, no uterine rigidity, and a normal fetal heart rate tracing), the standard approach is conservative management rather than immediate delivery. Clinical protocols from Fetal Medicine Barcelona recommend weekly ultrasound monitoring of the hematoma itself and biweekly assessments of fetal growth. Cardiotocography, which tracks the baby’s heart rate and uterine contractions, is used to check fetal well-being at each visit.
If the hematoma is stable or shrinking, and the baby continues to grow normally, pregnancy can often continue with close observation. If the clot expands, if signs of growth restriction appear, or if clinical signs of abruption develop, the medical team will reassess timing of delivery based on gestational age and the severity of the situation. It’s worth noting that a normal-looking ultrasound doesn’t fully rule out early abruption, so symptom awareness between appointments remains important.
What Influences Your Risk
Several factors increase the likelihood of developing a retroplacental hematoma. Chronic high blood pressure and preeclampsia top the list, since both put extra stress on the blood vessels supplying the placenta. Trauma to the abdomen, smoking, cocaine use, and a history of prior abruption also raise risk. In some cases, no clear cause is identified. The condition is more common in pregnancies complicated by rapid uterine decompression, such as after the rupture of membranes in a pregnancy with excess amniotic fluid.
Placental abruption from retroplacental hematoma is 5.6 times more likely in pregnancies where a hematoma was detected in the first trimester compared to those without one. Abnormalities in how the placenta separates after delivery are also about 3.2 times more common, suggesting that even hematomas that don’t cause overt abruption can affect placental attachment throughout pregnancy.